HDAC6介导的自噬在结核抵抗者产生中的作用机制
批准号:
82072243
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
逄宇
依托单位:
学科分类:
病原细菌与感染
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
逄宇
中文摘要
结核抵抗者(Resister)是指能将反复大量入侵的结核分枝杆菌(Mtb)完全清除的特殊人群。探究Resister产生机制对于实现易感人群精准干预,开辟结核免疫治疗的新途径具有重要意义,但其机制尚不清楚。我们前期研究发现Resister巨噬细胞对Mtb具有更强的杀灭作用,且组蛋白去乙酰化酶6(HDAC6)特异高表达于Resister巨噬细胞,对巨噬细胞清除Mtb可能有重要作用。据此提出假说Resister的巨噬细胞通过特异上调HDAC6介导的自噬,促进巨噬细胞对Mtb的杀灭作用。本研究拟利用原代巨噬细胞明确HDAC6对于噬细胞杀灭Mtb的作用;通过自噬流和蛋白可视化定量技术等探讨HDAC6表达对自噬分子信号通路的调控机制;利用细胞和动物模型评价HDAC6表达对自噬及巨噬细胞清除Mtb的影响,以阐明Resister产生的天然免疫机制,为探索预防结核感染及提高结核疗效的免疫干预策略奠定基础。
英文摘要
TB resistant (Resister) refers to a special population that can completely eliminate the Mycobacterium tuberculosis (Mtb) after long-term and large amount exposure to Mtb. Exploring the mechanism of resister is of great significance for achieving precise intervention in early high-risk populations and opening up a new approach to tuberculosis immunotherapy, but it remains unclear. Our previous study found that resister macrophages had a stronger killing effect on Mtb, and protein deacetylase 6 (HDAC6) was specifically highly expressed in resister macrophages, which may play an important role in the clearance of Mtb by macrophages. It was hypothesized that the macrophages of Resister specifically up-regulated HCDA6-mediated autophagy to promote the capability of macrophages to kill Mtb. In this study, primary macrophages were used as the model to determine the role of HDAC6 in killing Mtb by macrophages. The regulation mechanism of HDAC6 expression level on autophagy molecular signaling pathway was investigated by autophagy flow and protein visualization and quantitative techniques. Cell model and animal model were used to evaluate the effect of HDAC6 expression on the clearance of Mtb infection by macrophages, so as to elucidate the natural immune mechanism generated by resister, and lay a theoretical foundation for the formulation of effective intervention strategies to block the infection of TB susceptible populations and the improvement of immunotherapy programs for active TB patients.
结核抵抗者(Resister)是指能将反复大量入侵的结核分枝杆菌(Mtb)完全清除的特殊人群。探究Resister产生机制对于实现易感人群精准干预,开辟结核免疫治疗的新途径具有重要意义,但其机制尚不清楚。本研究项目发现Resister巨噬细胞对Mtb具有更强的杀灭作用 ,且组蛋白去乙酰化酶6(HDAC6)特异高表达于Resister巨噬细胞,同时Resister的巨噬细胞通过特异上调HDAC6介导的自噬,促进巨噬细胞对Mtb的杀灭作用。本研究阐明了HDAC6促进结核抵抗者巨噬细胞促炎细胞因子产生以及自噬流畅通进而加速Mtb清除的作用机制,为探索预防结核感染及提高结核疗效的免疫干预策略奠定基础。同时进一步以HDAC6为靶点确定泊马度胺介导HDAC6促进自噬从而参与细胞内和小鼠体内分枝杆菌的清除,完成泊马度胺作为结核病治疗的临床前研究,为结核病患者免疫治疗提供新型抗结核药物和新策略。本研究项目总计发表论文5篇,其中SCI论文4篇,总影响因子39.9分,申请专利2项,培养博士研究生2名。
结核特异性记忆样NK细胞表面受体CRTAM介导NF-κB信号通路释放IFN-γ清除结核分枝杆菌的分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:逄宇
-
依托单位:
国内基金
海外基金